Therefore, the targeting of GCS is considered a means of overcoming cancer progression and drug resistance in various cancers; however, the GCS expression level in CCA and its role in CCA chemoresistance remains unknown. The gene discussed is UGCG; the disease is cholangiocarcinoma.